Hair loss is predominantly discussed in the context of male pattern baldness, but it affects women in significant numbers. Female hair loss has distinct causes and patterns from male androgenic alopecia, and the approach to treatment — including whether a hair transplant is appropriate — differs accordingly.
The most common form of female hair loss is female pattern hair loss (FPHL), also called androgenetic alopecia in women. Unlike the receding hairline seen in men, FPHL typically presents as a widening of the parting and diffuse thinning across the top of the scalp, usually with retention of the frontal hairline. The Ludwig classification system describes three stages of severity.
Female hair loss can also result from iron deficiency, thyroid disorders, polycystic ovary syndrome, chronic stress (telogen effluvium), traction alopecia from tight hairstyles, scarring alopecia, and post-partum hormonal changes. Many of these causes are treatable with medical intervention, making diagnosis — through blood tests and in some cases scalp biopsy — an essential first step before any treatment is considered.
Hair transplant surgery is appropriate for some female patients — particularly those with stable androgenetic alopecia, traction alopecia, or hairline correction needs. However, because many women have diffuse thinning rather than defined bald areas, the donor zone can also be affected, which limits the suitability of surgery. A thorough assessment is essential to determine whether the donor supply is adequate and sufficiently stable.
For women who are suitable candidates, results from FUE transplants can be outstanding — restoring hairline definition, parting density, and overall appearance in a way that no non-surgical treatment achieves.
Related reading
